A detailed history of American Portfolios Advisors transactions in Zai Lab LTD stock. As of the latest transaction made, American Portfolios Advisors holds 14 shares of ZLAB stock, worth $385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Holding current value
$385
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$34.2 - $51.69 $478 - $723
14 New
14 $479,000
Q1 2021

Mar 22, 2023

SELL
$126.27 - $191.71 $252 - $383
-2 Reduced 14.29%
12 $1.6 Million
Q4 2020

Mar 22, 2023

BUY
$81.94 - $135.34 $521,957 - $862,115
6,370 Added 45500.0%
6,384 $864 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.7B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.